Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia

NCT01727232 is registered in ClinicalTrials.gov with Henri Mondor University Hospital as lead sponsor.

NCT NCT01727232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01727232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia
Lead sponsor
Henri Mondor University Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2007
Completion date
October 31, 2012
Enrollment
107 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary immune thrombocytopenia